| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |